Innovent Biologics, Inc. ( IVBXF) - Key Metrics
IVBXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.92 | $0.72 | $0 | $0 |
| 2025Q4 | $8.41 | -$0.02 | $11.65 | $11.38 |
| 2025Q2 | $3.51 | $0.49 | $0.19 | $0.12 |
| 2024Q4 | $3.35 | $0.18 | $0.92 | $0.76 |
| 2024Q2 | $2.44 | -$0.24 | -$0.13 | -$0.56 |
IVBXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 24.94 |
| 2025Q4 | 0% | -695.69 |
| 2025Q2 | 0% | 37.75 |
| 2024Q4 | 0% | 45.62 |
| 2024Q2 | 0% | -35.66 |
IVBXF
Price: $10.31
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 203.89
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 22.3 billion